ArticleNeuroradiology2026
An MRI-based radiomics model for precision subtyping of hereditary spastic paraplegia: discriminating SPG4 from SPG5.
Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundDifferentiating spastic paraplegia type 4 (SPG4) from type 5 (SPG5) is clinically relevant with differing therapeutic strategies, yet genetic testing remains limited necessitate alternative approaches. This study aimed to develop and validate an interpretable radiomics model based on spinal cord MRI for distinguishing SPG4 from SPG5.
methodsIn this prospective study, SPG4 (N = 40) and SPG5 (N = 30) were randomly assigned to training (n = 56) and test (n = 14) sets. Radiomic features were extracted from the whole spinal cord (WSC) and cervical spinal cord functional subregions (SCFS) on three-dimensional T1- and T2-weighted images. Predictive models were constructed using four machine learning algorithms and evaluated by receiver operating characteristic curve (ROC) analysis. Model robustness was assessed by permutation testing, and interpretability was provided through SHapley Additive exPlanations (SHAP).
resultsRadiomics models based on the WSC consistently outperformed those based on SCFS. The optimal WSC model, constructed with a linear support vector classifier on combined T1- and T2-weighted sequences, achieved an AUC of 1.00 in the test set. SHAP analysis identified five consensus features contributed significantly to discrimination between SPG4 and SPG5. All five features also showed significant differences between the two groups (p < 0.001), with the most influential feature (T1_original_shape_SurfaceVolumeRatio) correlating with disease severity as measured by the Spastic Paraplegia Rating Scale (r = 0.434, p < 0.01).
conclusionsSpinal cord radiomics enables accurate and interpretable differentiation between SPG4 and SPG5, providing a non-invasive adjunct to genetic testing. This approach offers objective imaging biomarkers that may support precision diagnosis, improve patient stratification in hereditary spastic paraplegia.
Indexed as
Identifiers
42257892What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.